These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1978315)

  • 1. Somatostatin inhibits neurally stimulated pancreatic secretion indirectly.
    Holst JJ; Schaffalitzky de Muckadell OB; Fahrenkrug J
    Pancreas; 1990 Sep; 5(5):611-4. PubMed ID: 1978315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of somatostatin on the external secretion of the pancreas of the rat.
    Chariot J; Roze C; Vaille C; Debray C
    Gastroenterology; 1978 Nov; 75(5):832-7. PubMed ID: 700325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nervous control of pancreatic endocrine secretion in pigs. IV. The effect of somatostatin on the insulin and glucagon responses to electrical vagal stimulation and to intraarterial acetylcholine.
    Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J
    Acta Physiol Scand; 1981; 113(3):273-8. PubMed ID: 6125083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic nervous control of pancreatic somatostatin secretion.
    Holst JJ; Jensen SL; Knuhtsen S; Nielsen OV
    Am J Physiol; 1983 Dec; 245(6):E542-8. PubMed ID: 6140851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and HCO3.
    Fahrenkrug J; Schaffalitzky de Muckadell OB; Holst JJ; Jensen SL
    Am J Physiol; 1979 Dec; 237(6):E535-40. PubMed ID: 517650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow.
    Wettergren A; Wøjdemann M; Holst JJ
    Am J Physiol; 1998 Nov; 275(5):G984-92. PubMed ID: 9815028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide: effect on exocrine secretion and release from isolated perfused porcine pancreas.
    Knuhtsen S; Holst JJ; Jensen SL; Knigge U; Nielsen OV
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G281-6. PubMed ID: 3976887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion.
    Holst JJ; Fahrenkrug J; Knuhtsen S; Jensen SL; Poulsen SS; Nielsen OV
    Regul Pept; 1984 Apr; 8(3):245-59. PubMed ID: 6379759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation.
    Müller MK; Kessel B; Hütt T; Kath R; Layer P; Goebell H
    Pancreas; 1988; 3(3):303-10. PubMed ID: 2455292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas.
    Holst JJ; Rasmussen TN; Harling H; Schmidt P
    Pancreas; 1993 Jan; 8(1):80-7. PubMed ID: 7678328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nervous control of gastro-pancreatic somatostatin secretion in pigs.
    Holst JJ; Sottimano C; Olesen M; Lindkaer S; Nielsen OV
    Peptides; 1981; 2 Suppl 2():215-21. PubMed ID: 6123987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nervous control of pancreatic exocrine secretion in pigs.
    Holst JJ; Schaffalitzky de Muckadell OB; Fahrenkrug J
    Acta Physiol Scand; 1979 Jan; 105(1):33-51. PubMed ID: 33532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
    Horiuchi A; Iwatsuki K; Ren LM; Kuroda T; Chiba S
    Eur J Pharmacol; 1993 Jun; 237(1):23-30. PubMed ID: 7689468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin inhibits pancreatic enzyme secretion at a central vagal site.
    Li Y; Owyang C
    Am J Physiol; 1993 Aug; 265(2 Pt 1):G251-7. PubMed ID: 8103634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin.
    Masuda M; Tomita H; Okubo K; Miyasaka K
    J Auton Nerv Syst; 1994 Dec; 50(2):131-8. PubMed ID: 7884153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibits cholecystokinin-induced pancreatic protein secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1995 May; 10(4):401-6. PubMed ID: 7792297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of somatostatin on gastric acid secretion in rats.
    Nishikawa H; Yokotani K; Fujiwara M
    Jpn J Pharmacol; 1987 Oct; 45(2):263-70. PubMed ID: 2893853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.
    Vatn MH; Schrumpf E; Hanssen KF; Myren J
    J Endocrinol Invest; 1980; 3(3):279-82. PubMed ID: 6159391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of somatostatin 14 on pure human pancreatic secretion.
    Gullo L; Priori P; Scarpignato C; Baldoni F; Mattioli G; Barbara L
    Dig Dis Sci; 1987 Oct; 32(10):1065-70. PubMed ID: 2888607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of secretin stimulation of the pancreas.
    Brown JC; Harper AA; Scratcherd T
    J Physiol; 1967 Jun; 190(3):519-30. PubMed ID: 4293133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.